Clinical pathology: upper and lower comprehensive notes detailed exam oriented

Reading File

Given the scope of "upper and lower comprehensive notes" — I need to clarify what system you're referring to before diving deep.

Asking for Preferences

Which body system does 'upper and lower' refer to? · What level of detail do you need?

Finding Sources

Good. Now let me pull the key respiratory pathology sections from Robbins (gold standard for clinical pathology exams) and Murray & Nadel's respiratory medicine simultaneously.

Finding Sources

Reading File

Excellent — I have extensive content from Robbins. The second read_file returned a huge amount of content. Let me now read the remaining sections I need from the block files to ensure comprehensive coverage of the whole respiratory tract.

Reading File

I now have very comprehensive content from Robbins block 5 covering the full respiratory tract. I have rich material on:

Upper respiratory tract (infections, common cold, pharyngitis, epiglottitis, laryngitis, nasopharynx carcinoma, laryngeal tumors)
ARDS/ALI
Atelectasis, pulmonary edema
Obstructive lung diseases (COPD, emphysema, chronic bronchitis, asthma, bronchiectasis)
Restrictive lung diseases (ILD, UIP/IPF, NSIP, DIP, sarcoidosis, HP, CWP, silicosis, asbestosis)
Pulmonary infections (pneumonia - lobar, bronchopneumonia, atypical/viral)
Lung tumors
Pulmonary hypertension
Pleural disease (mesothelioma, effusion)

Let me now synthesize all of this into comprehensive exam-oriented notes.Here are your comprehensive, exam-oriented clinical pathology notes on the upper and lower respiratory tract, based on Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease.

🫁 Clinical Pathology: Upper & Lower Respiratory Tract

Comprehensive Exam-Oriented Notes

PART I: UPPER RESPIRATORY TRACT PATHOLOGY

1. Acute Infections

Condition	Key Pathogens	Exam Pearls
Common Cold	Rhinovirus #1; also coronavirus, RSV, parainfluenza, influenza, adenovirus, group A Strep	~40% no organism identified; self-limited ≤1 week
Acute Pharyngitis	β-hemolytic Streptococcus, adenovirus	Strep → treat early → prevents peritonsillar abscess, post-streptococcal GN, acute rheumatic fever
Herpangina	Coxsackievirus A	Pharyngeal vesicles + ulcers
Infectious Mononucleosis	EBV	Important cause of exudative pharyngitis
Acute Epiglottitis	H. influenzae	Children; abrupt airway obstruction → maintain airway or fatal; incidence ↓ after Hib vaccine
Acute Laryngitis	Irritants, allergens, common cold viruses
Tuberculous Laryngitis	M. tuberculosis	Consequence of active cavitary TB; infected sputum coughed up
Diphtheritic Laryngitis	Corynebacterium diphtheriae	Classic dirty-gray pseudomembrane; exotoxin causes mucosal necrosis; sloughing → asphyxia; rare in vaccinated populations

⚡ Exam tip: Strep pharyngitis complications = rheumatic fever + post-streptococcal GN. Epiglottitis = airway emergency. Diphtheria pseudomembrane = fibrinopurulent exudate.

2. Nasopharyngeal Carcinoma

Association: EBV (strong, especially in endemic regions — Asia, Africa)
Histology: Undifferentiated carcinoma with prominent lymphocytic infiltrate ("lymphoepithelioma")
Location: Nasopharynx, near Eustachian tube opening
Clinical: Cervical lymphadenopathy, nasal obstruction, epistaxis
EBV serology (anti-VCA IgA) useful for diagnosis and monitoring
Radiosensitive — radiation is mainstay of treatment

⚡ Exam tip: EBV → Burkitt lymphoma (Africa), Hodgkin lymphoma (EBV+), infectious mono, nasopharyngeal carcinoma, post-transplant lymphoma, gastric carcinoma (subset).

3. Laryngeal Tumors

Vocal Cord Nodules ("Singer's Nodes")

Benign, fibrous, bilateral
Caused by vocal abuse (excessive talking/singing)

Laryngeal Papillomas / Papillomatosis

Caused by HPV types 6 and 11 (low-risk)
In children: recurrent respiratory papillomatosis — multiple lesions, high recurrence after excision
In adults: usually solitary
Rarely transforms to squamous cell carcinoma

Laryngeal Carcinoma (Squamous Cell Carcinoma)

Risk factors: Smoking (#1), alcohol, HPV infection, asbestos exposure
Location: Glottis most common (vocal cords) > supraglottic > subglottic
Glottic tumors: Present early with hoarseness; good prognosis (no lymphatics)
Supraglottic/subglottic: Present late with cervical LN mets; worse prognosis
Morphology: Pearly gray, wrinkled mucosa → ulcerating, fungating mass
Spreads: Direct extension to soft tissues of neck, trachea; metastases to regional LNs

⚡ Exam tip: Hoarseness in a smoker = laryngeal SCC until proven otherwise. Glottic = best prognosis. HPV 6/11 = papilloma; HPV 16/18 = SCC.

PART II: LOWER RESPIRATORY TRACT PATHOLOGY

4. Atelectasis (Collapse)

Type	Mechanism	Example
Resorption	Obstruction of airway → air absorbed distal to blockage	Mucus plug, foreign body, tumor
Compression	External compression collapses lung	Pleural effusion, pneumothorax, abdominal distension
Contraction	Fibrosis restricts expansion	Pulmonary/pleural fibrosis (cicatrization)
Microatelectasis	Loss of surfactant	Neonatal RDS, ARDS

⚡ Exam tip: Atelectasis (except contraction) is reversible. Treat promptly to prevent hypoxemia and secondary infection. Post-op atelectasis: most common cause of early post-op fever.

5. Pulmonary Edema

Hemodynamic (Cardiogenic):

↑ hydrostatic pressure (left heart failure, mitral stenosis)
Heavy, wet lungs; pink frothy fluid
Histology: engorged capillaries, alveolar fluid, hemosiderin-laden macrophages ("heart failure cells") = siderophages with iron from lysed RBCs

Noncardiogenic / ALI / ARDS:

↑ vascular permeability (not ↑ hydrostatic pressure)
No cardiac failure

6. Acute Lung Injury (ALI) & ARDS

Definition (Berlin criteria):

Respiratory failure within 1 week of insult
Bilateral opacities on imaging not explained by effusions/atelectasis/cardiac failure
Graded by PaO₂/FiO₂ ratio severity

Causes (triggers):

Most common	Other
Pneumonia (35–45%)	Aspiration
Sepsis (30–35%)	Trauma (brain injury, surgery, fractures)
	Pancreatitis, transfusion reactions (TRALI)
	COVID-19 pneumonia (subset)

Pathogenesis:

Proinflammatory mediators released (IL-1, TNF by macrophages)
Endothelial activation → neutrophil sequestration in pulmonary capillaries
Activated neutrophils release ROS, proteases → alveolar epithelial + endothelial injury
↑ permeability → edema, surfactant loss → stiff lungs
Hyaline membranes = protein-rich edema fluid + cellular debris lining alveolar walls

Morphology (3 phases):

Phase	Timing	Findings
Exudative	Days 1–7	Edema, fibrin, neutrophils, hyaline membranes, type I pneumocyte necrosis
Organizing	Week 2–3	Type II pneumocyte proliferation (regeneration), fibroblast ingrowth
Fibrotic	Weeks 3+	Collagen deposition, honeycombing if severe

⚡ Exam tip: Hyaline membranes = ARDS (adults) or neonatal RDS. ARDS ≠ cardiogenic pulmonary edema (bilateral but PCWP normal, no cardiac cause).

7. Obstructive Lung Diseases

Obstructive = ↓ FEV₁/FVC ratio (airflow limitation)

A. Emphysema

Definition: Permanent enlargement of airspaces distal to terminal bronchioles with destruction of alveolar walls without significant fibrosis.

Type	Location	Cause
Centriacinar (Centrilobular)	Central acinus (respiratory bronchioles)	Smoking #1; upper lobe predominance
Panacinar (Panlobular)	Entire acinus uniformly	α1-antitrypsin deficiency; lower lobe predominance
Paraseptal	Peripheral acinus adjacent to septa/pleura	Near scars; cause of spontaneous pneumothorax in young adults
Irregular (Scar)	Around scar tissue	Post-inflammatory scarring

Pathogenesis — Protease-Antiprotease Imbalance:

Smoking activates neutrophils/macrophages → release of elastase, MMPs
Destroys elastin in alveolar walls
Also inactivates α1-antitrypsin (antielastase) via oxidative stress
α1-AT deficiency → panacinar emphysema (PiZZ genotype; liver also affected)

Morphology:

Abnormally large airspaces with destroyed walls
Reduced surface area for gas exchange
Loss of elastic recoil → air trapping

Clinical ("Pink Puffer"):

Dyspnea, minimal cough, barrel chest, pursed-lip breathing
↑ AP diameter, hyperresonance, ↓ breath sounds
PFTs: ↓ FEV₁/FVC, ↑ TLC, ↑ RV, ↓ DLCO (lost alveolar surface)

⚡ Exam tip: α1-AT deficiency → PiZZ → panacinar emphysema + liver cirrhosis (misfolded protein accumulates in hepatocytes → PAS+ diastase-resistant globules). Treat with α1-AT replacement.

B. Chronic Bronchitis

Definition (Clinical): Productive cough for ≥3 months/year for ≥2 consecutive years without other cause.

Pathogenesis:

Irritants (smoke, pollutants) → goblet cell hyperplasia + submucosal gland hypertrophy → Reid index (gland thickness/wall thickness) >0.4 (normal <0.4)
Excess mucus → plugging, bacterial colonization (H. influenzae, S. pneumoniae)
Mucus hypersecretion + airflow obstruction

Morphology:

Hyperemia, edema, mucus secretions
Goblet cell metaplasia of bronchioles (normally absent)
Squamous metaplasia (precancerous)
Reid index >0.4 on histology

Clinical ("Blue Bloater"):

Productive cough, frequent infections, cyanosis
↑ CO₂ retention, cor pulmonale
PFTs: ↓ FEV₁/FVC, normal/↑ DLCO

⚡ Exam tip: Pink puffer = emphysema (maintain PO₂ by hyperventilating). Blue bloater = chronic bronchitis (hypercapnia, cyanosis). In reality, most COPD patients overlap.

C. Asthma

Definition: Chronic airway inflammation causing reversible bronchospasm, hyperresponsiveness.

Types:

Type	Features
Atopic (Extrinsic/Allergic)	Childhood onset; IgE-mediated (Type I HSR); elevated serum IgE; positive skin tests; triggers: allergens
Non-atopic (Intrinsic)	Adult onset; no family history; triggers: infection (viral URTIs), exercise, cold air, stress
Drug-induced	Aspirin → blocks COX → shunts arachidonic acid to lipoxygenase → excess leukotrienes (LTC4, LTD4, LTE4) → bronchoconstriction
Occupational	Workplace dusts, chemicals

Pathogenesis (Atopic):

Sensitization: allergen → TH2 response → IL-4, IL-5, IL-13 → IgE production, mast cell sensitization, eosinophil recruitment
Early phase (minutes): IgE cross-linking → mast cell degranulation → histamine, leukotrienes, prostaglandins → bronchoconstriction
Late phase (4–8 hrs): eosinophils, neutrophils → tissue damage, mucus hypersecretion, inflammation

Morphology:

Airway wall thickening (smooth muscle hypertrophy, subepithelial fibrosis)
Curschmann spirals (shed epithelium forming mucus plugs = whorled casts)
Charcot-Leyden crystals (eosinophil membrane protein, bipyramidal)
Eosinophilic infiltrate in mucosa and lumen
Goblet cell hyperplasia, basement membrane thickening

Status asthmaticus: Prolonged attack unresponsive to bronchodilators → fatal if untreated

⚡ Exam tip: Curschmann spirals + Charcot-Leyden crystals = asthma sputum hallmarks. Aspirin-exacerbated respiratory disease = blocked COX → leukotriene excess. Treat with leukotriene antagonists (montelukast).

D. Bronchiectasis

Definition: Permanent dilation of bronchi/bronchioles due to destruction of bronchial walls.

Causes (mnemonic ABCDE):

A: Allergic bronchopulmonary aspergillosis (ABPA)
B: Bronchial obstruction (tumor, foreign body)
C: Cystic fibrosis, Kartagener/ciliary dyskinesia
D: Destruction from infection (necrotizing pneumonia, TB, whooping cough)
E: Immune deficiency (hypogammaglobulinemia)

Pathogenesis: Obstruction + infection → chronic inflammation → proteolytic destruction of bronchial wall → permanent dilation

Morphology:

Dilated bronchi/bronchioles extending to pleural surface (normally bronchi don't reach pleura)
Pus-filled cavities, mucosal ulceration
Lower lobe predominance

Clinical:

Copious purulent sputum (3-layered: frothy, mucopurulent, turbid)
Hemoptysis
Clubbing, recurrent pneumonia
Cor pulmonale in severe disease

⚡ Exam tip: Kartagener syndrome = bronchiectasis + situs inversus + sinusitis (ciliary dynein arm defect, autosomal recessive). CF = most common genetic cause of bronchiectasis in Caucasians.

8. Restrictive Lung Diseases (Interstitial Lung Diseases)

Restrictive = ↓ lung compliance → ↓ TLC, ↓ FVC; FEV₁/FVC normal or ↑; ↓ DLCO

A. Idiopathic Pulmonary Fibrosis (IPF) / Usual Interstitial Pneumonia (UIP)

Definition: Progressive fibrosis of lung parenchyma of unknown cause.

Key features:

Adults >50 years, M>F, smokers
UIP pattern on HRCT: subpleural, basal, bilateral honeycombing with traction bronchiectasis
Histology: temporal heterogeneity — areas of normal lung next to fibrotic foci and fibroblast foci (distinct from NSIP which is uniform)
Fibroblast foci = hallmark of UIP
Progressive dyspnea, dry cough → respiratory failure
Median survival: 3–5 years
Treatment: Pirfenidone, nintedanib (slow progression); lung transplant

⚡ Exam tip: IPF/UIP = temporal and spatial heterogeneity, subpleural/basal honeycombing, fibroblast foci. Poor prognosis. No effective anti-inflammatory therapy.

B. Nonspecific Interstitial Pneumonia (NSIP)

Associated with connective tissue diseases (scleroderma, polymyositis, RA, SLE)
Uniform interstitial inflammation and fibrosis (vs. UIP heterogeneity)
Better prognosis than UIP; responds to steroids
Two patterns: cellular NSIP (better) vs. fibrotic NSIP

C. Cryptogenic Organizing Pneumonia (COP) / BOOP

Plugs of granulation tissue fill bronchioles and alveolar ducts (Masson bodies)
Responds well to corticosteroids (dramatic response)
Peripheral patchy consolidations on CT ("reverse halo sign")

D. Desquamative Interstitial Pneumonia (DIP)

Smokers
Alveoli filled with macrophages (misnamed as "desquamated cells")
Relatively benign; responds to smoking cessation + steroids

E. Sarcoidosis

Systemic non-caseating granulomatous disease of unknown cause
Most common in young Black women
Bilateral hilar lymphadenopathy (BHL) = hallmark on CXR
Non-caseating granulomas in lung, lymph nodes, skin, eyes, liver, heart
Granuloma contents: Epithelioid macrophages, Langhans giant cells, Schaumann bodies (calcified inclusions), asteroid bodies (stellate inclusions)
Serum ACE elevated (from epithelioid cells)
Hypercalcemia (granulomas produce 1,25-OH₂ vitamin D)
Lupus pernio (violaceous skin plaques), uveitis, CN VII palsy
Löfgren syndrome (acute sarcoid): BHL + erythema nodosum + arthritis → good prognosis
Treatment: Corticosteroids; most resolve spontaneously

⚡ Exam tip: Non-caseating = sarcoidosis. Caseating = TB. Elevated ACE + BHL + hypercalcemia = sarcoidosis. Serum ACE not specific (also elevated in Gaucher disease, hyperthyroidism).

F. Hypersensitivity Pneumonitis (HP) / Extrinsic Allergic Alveolitis

Etiology: Inhaled organic antigens → combined Type III + Type IV HSR

Antigen source	Disease
Thermophilic actinomycetes (moldy hay)	Farmer's Lung
Avian proteins (bird droppings)	Bird Fancier's Lung
Thermophilic actinomycetes (HVAC)	Humidifier Lung

Histology: Poorly-formed, non-caseating granulomas + lymphocytic interstitial inflammation (vs. sarcoid which is well-formed)

Acute: 4–8 hrs after exposure; fever, chills, dyspnea (flu-like) Chronic: Persistent fibrosis if antigen not removed

G. Pneumoconioses (Dust Diseases)

Disease	Dust	Key Pathology	Notes
Coal Workers' Pneumoconiosis (CWP)	Coal dust	Simple: coal macules (dust + macrophages); Progressive Massive Fibrosis (PMF): large black scars	Caplan syndrome = CWP + RA → large necrotic nodules
Silicosis	Crystalline silica	Birefringent silica particles in whorled, concentric collagen nodules ("egg-shell" calcification of hilar LNs)	↑ risk of TB ("silicotuberculosis"); foundry workers, sandblasters
Asbestosis	Asbestos	Diffuse interstitial fibrosis + asbestos bodies (ferruginous bodies = asbestos fiber coated with iron-protein = "beaded rod" with clubbed ends)	Mesothelioma (pleural, peritoneal) — strongest link; also ↑ lung cancer; pleural plaques (calcified) = most common manifestation

⚡ Exam tip: Silicosis nodules = birefringent (polarized light), upper lobe. Asbestosis = lower lobe fibrosis. Asbestos → mesothelioma (not silica). Ferruginous bodies = BAL/biopsy finding. Caplan syndrome = nodules in CWP patient with RA.

9. Pulmonary Infections (Pneumonia)

Classification by Pattern:

Pattern	Distribution	Etiology
Lobar Pneumonia	Entire lobe consolidated	S. pneumoniae #1
Bronchopneumonia	Patchy, bilateral, peribronchial	S. aureus, K. pneumoniae, H. influenzae, Gram-negatives
Interstitial (Atypical)	Diffuse bilateral, interstitial	Mycoplasma, viruses, Chlamydia, Legionella

Lobar Pneumonia — Stages:

Stage	Timing	Gross	Histology
Congestion	Day 1–2	Heavy, red	Vascular engorgement, edema, few bacteria
Red Hepatization	Day 3–4	Red, liver-like, airless	Fibrin + RBCs + neutrophils fill alveoli
Gray Hepatization	Day 5–7	Gray, dry	RBCs lysed; fibrin + neutrophils + macrophages
Resolution	Day 8+	Normal	Enzymatic digestion of exudate; macrophage cleanup

Complications: Abscess, empyema, organizing pneumonia, bacteremia, meningitis, endocarditis

Atypical Pneumonia:

Organism	Key Feature
Mycoplasma pneumoniae	Most common cause of community-acquired atypical pneumonia in young adults; cold agglutinins (anti-I IgM); treat with macrolides/tetracyclines
Legionella pneumophila	Contaminated water/AC systems; Pontiac fever (mild) vs. Legionnaires' disease (severe); silver stain, urine antigen test; treat with fluoroquinolones/macrolides
Chlamydia pneumoniae	Common community-acquired pneumonia
Pneumocystis jirovecii (PCP)	Immunocompromised (AIDS, CD4<200); frothy alveolar exudate; silver/GMS stain shows cup-shaped cysts; treat with TMP-SMX

Important Organisms by Clinical Context:

Setting	Organism
Community-acquired, healthy adult	S. pneumoniae, Mycoplasma, Chlamydia
Alcoholic/aspiration	K. pneumoniae ("currant jelly sputum"), anaerobes
Hospital-acquired/ventilator	P. aeruginosa, S. aureus (MRSA), Gram-negatives
Immunocompromised (AIDS)	PCP, CMV, Cryptococcus, MAC, Histoplasma
Elderly/nursing home	S. pneumoniae, H. influenzae, Gram-negatives
Young child	RSV, parainfluenza (croup)

Tuberculosis (Pulmonary):

Primary TB:

Initial infection in a non-immune host
Ghon focus (subpleural consolidation, usually lower upper lobe) + hilar LN involvement = Ghon complex (Ranke complex)
Most contain and heal (calcify); 5–10% progress

Secondary (Reactivation) TB:

Apex of upper lobes (high O₂ tension favors growth)
Caseous necrosis → cavitation
Spread: endobronchial, hematogenous (miliary TB)
Miliary TB: Hematogenous spread → innumerable small granulomas (millet seed appearance)
Histology: caseating granulomas with central necrosis, Langhans giant cells, epithelioid macrophages

Diagnosis: AFB smear/culture (gold standard), Mantoux PPD, IGRA (QuantiFERON), PCR

⚡ Exam tip: Primary TB = Ghon focus (lower lobe) + hilar LN. Secondary TB = upper lobe cavitation. Miliary TB = hematogenous dissemination. Ghon complex = healed primary TB (calcified).

10. Lung Tumors

Classification of Lung Carcinomas:

Lung Carcinoma
├── Non-Small Cell (NSCLC) — 85%
│   ├── Adenocarcinoma — most common overall
│   ├── Squamous Cell Carcinoma
│   └── Large Cell Carcinoma
└── Small Cell Carcinoma (SCLC) — 15%

Adenocarcinoma

Feature	Detail
Most common	Lung cancer overall (both smokers + non-smokers)
Location	Peripheral (subpleural)
Origin	Type II pneumocytes, Clara cells
Histology	Acinar, papillary, micropapillary, lepidic (growth along alveolar walls) patterns; mucin production
Precursor	Atypical adenomatous hyperplasia → adenocarcinoma in situ (AIS, formerly BAC)
Driver mutations	EGFR (common in non-smokers, Asian women), KRAS (smokers, poor prognosis), ALK rearrangement (EML4-ALK), ROS1
Treatment	EGFR inhibitors (erlotinib, gefitinib); ALK inhibitors (crizotinib)

⚡ Exam tip: EGFR mutation = never/light smokers, Asian women, adenocarcinoma → responds to TKIs. ALK rearrangement = younger patients, adenocarcinoma → crizotinib.

Squamous Cell Carcinoma

Feature	Detail
Location	Central (near hilum, main bronchi)
Association	Smoking (strongest link)
Histology	Keratin pearls, intercellular bridges (desmosomes), squamous differentiation
Precursor	Squamous metaplasia → dysplasia → carcinoma in situ → invasive
Paraneoplastic	PTHrP → hypercalcemia (most common paraneoplastic syndrome of SCC)
Cavitation	Frequent (central necrosis)

⚡ Exam tip: Central mass + cavitation + hypercalcemia (PTHrP) = SCC. Hemoptysis in smoker = SCC. Pancoast tumor = apex tumor → Horner syndrome (ptosis, miosis, anhidrosis) + C8-T1 plexopathy.

Small Cell Carcinoma (SCLC)

Feature	Detail
Location	Central, perihilar
Association	Heavy smoking (most strongly associated)
Origin	Neuroendocrine cells (Kulchitsky cells)
Histology	Small cells, scant cytoplasm, salt-and-pepper chromatin, numerous mitoses, crush artifact, no nucleoli
Neuroendocrine markers	Chromogranin, synaptophysin, NSE, CD56
Paraneoplastics	SIADH (ADH-like peptide → hyponatremia); Cushing syndrome (ectopic ACTH); Eaton-Lambert syndrome (antibodies vs. presynaptic Ca²⁺ channels)
Prognosis	Worst; early systemic spread; not resectable — chemotherapy (etoposide + cisplatin)

⚡ Exam tip: SCLC = neuroendocrine + paraneoplastic syndromes. SIADH + Cushing + Eaton-Lambert = SCLC. NOT surgical candidate. Lambert-Eaton improves with repeated stimulation (vs. MG which worsens).

Large Cell Carcinoma

Undifferentiated; diagnosis of exclusion
Peripheral mass, anaplastic cells
Poor prognosis

Carcinoid Tumors

Feature	Detail
Type	Well-differentiated neuroendocrine neoplasm
Location	Central (typical) or peripheral
Association	No smoking association
Histology	Uniform cells in organoid/trabecular pattern; neuroendocrine markers positive
Carcinoid syndrome	Flushing, diarrhea, wheezing, right-sided heart disease — only if hepatic mets present
Prognosis	Good (typical carcinoid); atypical carcinoid = more aggressive

Mesothelioma

Malignant tumor of pleural mesothelial cells
Asbestos exposure (strongest RF; 25–45 year latency); chrysotile and amphibole types (crocidolite most carcinogenic)
Does NOT require smoking
Histology: Biphasic (epithelioid + sarcomatoid) or pure epithelioid/sarcomatoid; calretinin+, CK5/6+, WT-1+, CEA−, TTF-1−
Clinical: Dyspnea, chest wall pain, bloody pleural effusion, pleural thickening
Spreads along pleural surfaces, encases lung
Nearly uniformly fatal; median survival 12–18 months

⚡ Exam tip: Mesothelioma vs. adenocarcinoma (pleural mets): Mesothelioma = calretinin+, CEA−. Adenocarcinoma = TTF-1+, CEA+, calretinin−. Asbestos → mesothelioma + lung adenocarcinoma.

11. Pulmonary Hypertension

Definition: Mean pulmonary artery pressure ≥25 mmHg at rest

WHO Classification:

Group	Cause
1	Pulmonary arterial hypertension (idiopathic, heritable [BMPR2], connective tissue disease, drugs)
2	Left heart disease (mitral stenosis, LV failure)
3	Chronic lung disease/hypoxia (COPD, ILD, obstructive sleep apnea)
4	Chronic thromboembolic (recurrent PE)
5	Multifactorial (sarcoidosis, schistosomiasis)

Idiopathic PAH (Group 1):

Young women predominantly
BMPR2 mutations (75% familial, 25% sporadic) — normally inhibits smooth muscle proliferation; loss → smooth muscle hypertrophy
Fatal without treatment; prostacyclin analogues, endothelin antagonists, PDE5 inhibitors

Morphology:

Medial hypertrophy of pulmonary arteries
Intimal fibrosis (onion-skin)
Plexiform lesions (characteristic of severe pulmonary hypertension — tufts of capillaries spanning dilated vessels)
Right ventricular hypertrophy → cor pulmonale

⚡ Exam tip: BMPR2 = heritable PAH. Plexiform lesions = most severe pulmonary hypertension. Cor pulmonale = RV hypertrophy/dilation from pulmonary disease.

12. Pulmonary Embolism (PE)

~95% arise from deep leg veins (DVT)
Virchow's triad: Stasis, hypercoagulability, endothelial injury
Most PEs are clinically silent (small peripheral emboli)
Large/saddle emboli → sudden death (obstructive shock)
Hemorrhagic (red) infarcts in lower lobes (dual blood supply prevents true infarction usually)
Pulmonary hemorrhage (not true infarct) in most cases
True infarct only when bronchial circulation also compromised (e.g., heart failure)

Clinical:

Small: asymptomatic
Medium: pleuritic chest pain, hemoptysis, pleural rub
Large: sudden dyspnea, hypoxia, hypotension, right heart strain (S1Q3T3 on ECG)
Massive: circulatory collapse, sudden death

Diagnosis: CT-PA (gold standard); V/Q scan; D-dimer (sensitive, not specific)

⚡ Exam tip: Hampton's hump = wedge-shaped pleural-based opacity on CXR (infarct). Westermark sign = oligemia distal to embolus. Saddle embolus = bifurcation of pulmonary trunk → sudden death. Paradoxical embolism = venous embolus crosses patent foramen ovale → systemic arterial embolism.

13. Pleural Disease

Pleural Effusion Types:

Type	Protein	LDH	Cause
Transudate	Low (<3 g/dL)	Low	Heart failure, cirrhosis, nephrotic syndrome
Exudate	High (>3 g/dL)	High	Infection (empyema), malignancy, pulmonary infarction, inflammation

Light's criteria (exudate if ANY):

Pleural/serum protein >0.5
Pleural/serum LDH >0.6
Pleural LDH >2/3 upper limit of normal serum LDH

Pneumothorax:

Type	Cause
Spontaneous (primary)	Tall, thin young men; rupture of subpleural blebs/bullae (paraseptal emphysema)
Secondary	Emphysema, asthma, CF, TB cavity, trauma
Tension	Air enters but can't escape; mediastinal shift; emergency decompression

🔑 HIGH-YIELD EXAM SUMMARY

Paraneoplastic Syndromes in Lung Cancer:

Tumor	Syndrome	Mediator
Squamous cell	Hypercalcemia	PTHrP
Small cell	SIADH	ADH-like peptide
Small cell	Cushing syndrome	ACTH
Small cell	Eaton-Lambert	Anti-VGCC antibodies
Carcinoid	Carcinoid syndrome	Serotonin (with liver mets)

Key Stains & Markers:

Finding	Significance
Curschmann spirals	Asthma sputum (mucus casts)
Charcot-Leyden crystals	Asthma (eosinophil membrane protein)
Hyaline membranes	ARDS, neonatal RDS
Ferruginous/asbestos bodies	Asbestosis (iron-coated fibers)
Birefringent nodules	Silicosis
PAS+ diastase-resistant globules in liver	α1-AT deficiency
Non-caseating granulomas	Sarcoidosis, HP, Crohn's, berylliosis
Caseating granulomas	TB, histoplasmosis, coccidioidomycosis
Calretinin+, CK5/6+, WT-1+	Mesothelioma
TTF-1+	Adenocarcinoma of lung, thyroid
Chromogranin, synaptophysin	Neuroendocrine tumors (SCLC, carcinoid)

FEV₁/FVC Patterns:

Pattern	FEV₁/FVC	TLC	Causes
Obstructive	↓ (<0.70)	Normal/↑	Asthma, COPD, bronchiectasis
Restrictive	Normal/↑ (>0.70)	↓	ILD, pleural disease, neuromuscular
Mixed	↓	↓	Sarcoidosis, severe COPD
DLCO ↓	—	—	Emphysema, ILD, PE, pulmonary HTN

Lung Cancer Comparison Table:

Feature	Squamous	Adeno	SCLC	Large Cell
Location	Central	Peripheral	Central	Peripheral
Smoking	+++	+ (non-smokers too)	++++	++
Histology	Keratin pearls	Glandular/mucin	Small oat cells	Anaplastic
Paraneoplastic	Hypercalcemia (PTHrP)	None typical	SIADH, Cushing, Eaton-Lambert	None typical
Surgery	Yes (if resectable)	Yes (if resectable)	No	Yes (rarely)
Prognosis	Intermediate	Better (targetable)	Worst	Poor

*Sources: Robbins & Kumar Basic Pathology 10th ed.; Robbins, Cotran & Kumar Pathologic Basis of Disease 10th ed.*These notes cover the entire respiratory tract from top to bottom. Here's a quick orientation guide:

How to Use These Notes

Upper Respiratory Tract (Part I):

Acute infections → common cold, pharyngitis, epiglottitis, laryngitis, diphtheria
Nasopharyngeal carcinoma (EBV)
Laryngeal tumors: nodules, papilloma (HPV 6/11), SCC (smoking)

Lower Respiratory Tract (Part II):

Topic	Key Exam Points
Atelectasis	3 types + reversibility
ARDS	Diffuse alveolar damage, hyaline membranes, neutrophil-mediated
Emphysema	Centriacinar (smoking) vs. panacinar (α1-AT); protease-antiprotease
Chronic Bronchitis	Reid index >0.4; blue bloater
Asthma	Curschmann + Charcot-Leyden; aspirin → LTs; status asthmaticus
Bronchiectasis	Kartagener, CF, ABPA
ILD (UIP/IPF)	Temporal heterogeneity, fibroblast foci, basal/subpleural, poor Px
Sarcoidosis	Non-caseating granulomas, BHL, ACE↑, hypercalcemia
Pneumoconioses	Silicosis (birefringent, TB risk), Asbestosis (ferruginous bodies, mesothelioma)
Pneumonia	Lobar stages (congestion → red → gray → resolution)
TB	Ghon complex (primary) vs. apical cavitation (secondary)
Lung cancers	Location, paraneoplastics, mutations
Pulmonary HTN	BMPR2, plexiform lesions, WHO groups
PE	DVT origin, Hampton's hump, Westermark sign
Mesothelioma	Asbestos, calretinin+, CEA−

The summary tables at the end are optimized for last-minute exam review. Let me know if you want any section expanded, a deeper dive into a specific topic, or practice MCQs.

This is a shared conversation. Sign in to Orris to start your own chat.